Millions of people with diabetes
rely on blood glucose monitors
to regulate their blood sugar. While the tests have become less expensive and less painful for patients, a post in Kaiser Health News’ Capsules blog
explains that these monitors may not always be accurate. One expert says “the FDA
is limited in its response because some manufacturers are in Asia, and the agency must rely on the manufacturers’ own studies related to accuracy … manufacturers don’t have much incentive to improve accuracy because federal law requires only that they prove they are ‘substantially equivalent’ to another meter already on the market.”
Read it in KHN’s Capsules blog.